Radiation dose reduction for CT-guided intrathecal nusinersen administration in adult patients with spinal muscular atrophy

被引:9
|
作者
Cordts, Isabell [1 ]
Deschauer, Marcus [1 ]
Lingor, Paul [1 ]
Burian, Egon [2 ]
Baum, Thomas [2 ]
Zimmer, Claus [2 ]
Maegerlein, Christian [2 ]
Sollmann, Nico [2 ,3 ]
机构
[1] Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Munich, Germany
[2] Tech Univ Munich, Dept Diagnost & Intervent Neuroradiol, Klinikum Rechts Isar, Munich, Germany
[3] Tech Univ Munich, TUM Neuroimaging Ctr, Klinikum Rechts Isar, Munich, Germany
关键词
LUMBAR PUNCTURE;
D O I
10.1038/s41598-020-60240-x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Intrathecal administration of nusinersen in adult spinal muscular atrophy (SMA) patients with scoliosis and spondylodesis requires image guidance, which is preferably achieved with multi-detector computed tomography (MDCT). As long-term treatment is necessary and patients are young, radiation doses should be reduced to a minimum whilst a sufficient image quality for precise interventional performance should be kept. We compared 44 MDCT standard-dose scans (133.0-200.0 mA) with a hybrid iterative reconstruction (iDose4) to 20 low-dose scans (20.0-67.0 mA) with iterative model reconstruction (IMR), which were performed for procedure planning of intrathecal nusinersen administration in 13 adult patients with SMA and complex spinal conditions. Qualitative image evaluation, including confidence for intervention planning, was performed by two neuroradiologists for standard- and low-dose scans. All 64 MDCT-guided intrathecal administrations of nusinersen were successful. The dose length product (DLP) was significantly lower when using low-dose scanning with IMR (median DLP of standard-dose scans: 92.0 mGy.cm vs. low-dose scans: 34.5 mGy.cm; p < 0.0001). Image quality was significantly reduced for low-dose compared to standard-dose scanning. However, bone/soft tissue contrast and confidence for intervention planning were not significantly impaired in low-dose MDCT according to both readers, showing good inter-reader agreement. Thus, we hereby demonstrate a low-dose MDCT protocol combined with advanced image reconstruction for scanning during procedure planning as a viable option for image guidance in intrathecal nusinersen treatment of adult SMA patients with complex spinal conditions.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Radiation dose reduction for CT-guided intrathecal nusinersen administration in adult patients with spinal muscular atrophy
    Isabell Cordts
    Marcus Deschauer
    Paul Lingor
    Egon Burian
    Thomas Baum
    Claus Zimmer
    Christian Maegerlein
    Nico Sollmann
    Scientific Reports, 10
  • [2] Radiation exposure of image-guided intrathecal administration of nusinersen to adult patients with spinal muscular atrophy
    D. Oldenburg
    N. Guberina
    B. Stolte
    K. Kizina
    E. Stenzel
    A. Radbruch
    C. Kleinschnitz
    T. Hagenacker
    M. Forsting
    C. Mönninghoff
    Neuroradiology, 2019, 61 : 565 - 574
  • [3] Radiation exposure of image-guided intrathecal administration of nusinersen to adult patients with spinal muscular atrophy
    Oldenburg, D.
    Guberina, N.
    Stolte, B.
    Kizina, K.
    Stenzel, E.
    Radbruch, A.
    Kleinschnitz, C.
    Hagenacker, T.
    Forsting, M.
    Moenninghoff, C.
    NEURORADIOLOGY, 2019, 61 (05) : 565 - 574
  • [4] Ultra-low radiation dose protocol for CT-guided intrathecal nusinersen injections for patients with spinal muscular atrophy and severe scoliosis
    Rosiak, Grzegorz
    Lusakowska, Anna
    Milczarek, Krzysztof
    Konecki, Dariusz
    Fraczek, Anna
    Rowinski, Olgierd
    Kostera-Pruszczyk, Anna
    NEURORADIOLOGY, 2021, 63 (04) : 539 - 545
  • [5] Ultra-low radiation dose protocol for CT-guided intrathecal nusinersen injections for patients with spinal muscular atrophy and severe scoliosis
    Grzegorz Rosiak
    Anna Lusakowska
    Krzysztof Milczarek
    Dariusz Konecki
    Anna Fraczek
    Olgierd Rowinski
    Anna Kostera-Pruszczyk
    Neuroradiology, 2021, 63 : 539 - 545
  • [6] Intrathecal nusinersen administration in adult spinal muscular atrophy patients with complex spinal anatomy
    Cordts, Isabell
    Lingor, Paul
    Friedrich, Benjamin
    Pernpeintner, Verena
    Zimmer, Claus
    Deschauer, Marcus
    Maegerlein, Christian
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2020, 13
  • [7] Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophy
    Stolte, Benjamin
    Totzeck, Andreas
    Kizina, Kathrin
    Bolz, Saskia
    Pietruck, Lena
    Moenninghoff, Christoph
    Guberina, Nika
    Oldenburg, Denise
    Forsting, Michael
    Kleinschnitz, Christoph
    Hagenacker, Tim
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11
  • [8] Ultrasound assisted lumbar intrathecal administration of nusinersen in adult patients with spinal muscular atrophy: A case series
    Zanfini, Bruno Antonio
    Catarci, Stefano
    Patanella, Agata Katia
    Pane, Marika
    Frassanito, Luciano
    Filipponi, Eleonora
    Mercuri, Eugenio
    Sabatelli, Mario
    Draisci, Gaetano
    MUSCLE & NERVE, 2021, 64 (05) : 594 - 599
  • [9] NUSINERSEN IN ADULT SPINAL MUSCULAR ATROPHY PATIENTS
    Fadia, Mithila
    Shroff, Sheetal
    Simpson, Ericka
    MUSCLE & NERVE, 2019, 60 : S54 - S54
  • [10] Intrathecal administration of nusinersen in adult and adolescent patients with spinal muscular atrophy and scoliosis: Transforaminal versus conventional approach
    Bortolani, Sara
    Stura, Guido
    Ventilii, Giancarlo
    Vercelli, Liliana
    Rolle, Enrica
    Ricci, Federica
    Bergui, Mauro
    Mongini, Tiziana
    NEUROMUSCULAR DISORDERS, 2019, 29 (10) : 742 - 746